BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 22045700)

  • 1. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults.
    Beachler DC; Weber KM; Margolick JB; Strickler HD; Cranston RD; Burk RD; Wiley DJ; Minkoff H; Reddy S; Stammer EE; Gillison ML; D'Souza G
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):122-33. PubMed ID: 22045700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of anal vs oral HPV infection in HIV-infected men and women.
    Beachler DC; D'Souza G; Sugar EA; Xiao W; Gillison ML
    J Infect Dis; 2013 Jul; 208(2):330-9. PubMed ID: 23596319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of medication use with clearance or persistence of oral HPV infection.
    Lam JO; Sugar EA; Cranston RD; Weber KM; Burk RD; Wiley DJ; Reddy S; Margolick JB; Strickler HD; Wentz A; Jacobson L; Coles CL; Bream JH; Rositch AF; Guo Y; Xiao W; Gillison ML; D'Souza G
    Cancer Causes Control; 2016 Dec; 27(12):1491-1498. PubMed ID: 27804058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.
    Beachler DC; Sugar EA; Margolick JB; Weber KM; Strickler HD; Wiley DJ; Cranston RD; Burk RD; Minkoff H; Reddy S; Xiao W; Guo Y; Gillison ML; D'Souza G
    Am J Epidemiol; 2015 Jan; 181(1):40-53. PubMed ID: 25480823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Oral Human Papillomavirus Infection Among Young Men Who Have Sex With Men-2 Cities, United States, 2012-2014.
    Oliver SE; Gorbach PM; Gratzer B; Steinau M; Collins T; Parrish A; Kerndt PR; Crosby RA; Unger ER; Markowitz LE; Meites E
    Sex Transm Dis; 2018 Oct; 45(10):660-665. PubMed ID: 30204745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of oral HPV infection in the United States, 2009-2010.
    Gillison ML; Broutian T; Pickard RK; Tong ZY; Xiao W; Kahle L; Graubard BI; Chaturvedi AK
    JAMA; 2012 Feb; 307(7):693-703. PubMed ID: 22282321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. Men.
    Chaturvedi AK; Graubard BI; Broutian T; Pickard RK; Tong ZY; Xiao W; Kahle L; Gillison ML
    Cancer Res; 2015 Jun; 75(12):2468-77. PubMed ID: 25873485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study.
    van Aar F; Mooij SH; van der Sande MA; Meijer CJ; King AJ; Verhagen DW; Heijman T; Coutinho RA; Schim van der Loeff MF
    BMC Infect Dis; 2014 Dec; 14():668. PubMed ID: 25551194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women.
    Fakhry C; D'souza G; Sugar E; Weber K; Goshu E; Minkoff H; Wright R; Seaberg E; Gillison M
    J Clin Microbiol; 2006 Dec; 44(12):4479-85. PubMed ID: 17021055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer.
    D'Souza G; McNeel TS; Fakhry C
    Ann Oncol; 2017 Dec; 28(12):3065-3069. PubMed ID: 29059337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and determinants of oral infection by Human Papillomavirus in HIV-infected and uninfected men who have sex with men.
    Rollo F; Latini A; Pichi B; Colafigli M; Benevolo M; Sinopoli I; Sperduti I; Laquintana V; Fabbri G; Frasca M; Cristaudo A; Giuliani M; Donà MG
    PLoS One; 2017; 12(9):e0184623. PubMed ID: 28910359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Human Papillomavirus Infection and Oral Lesions in HIV-Positive and HIV-Negative Dental Patients.
    Muller K; Kazimiroff J; Fatahzadeh M; Smith RV; Wiltz M; Polanco J; Grossberg RM; Belbin TJ; Strickler HD; Burk RD; Schlecht NF
    J Infect Dis; 2015 Sep; 212(5):760-8. PubMed ID: 25681375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of oral HPV infection among a multinational sample of healthy men.
    Kreimer AR; Villa A; Nyitray AG; Abrahamsen M; Papenfuss M; Smith D; Hildesheim A; Villa LL; Lazcano-Ponce E; Giuliano AR
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):172-82. PubMed ID: 21148755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-month incidence and persistence of oral HPV infection in HIV-negative and HIV-infected men who have sex with men.
    Mooij SH; Boot HJ; Speksnijder AG; Meijer CJ; King AJ; Verhagen DW; de Vries HJ; Quint WG; Molijn A; de Koning MN; van der Sande MA; van der Loeff MF
    PLoS One; 2014; 9(6):e98955. PubMed ID: 24896848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of human papillomavirus genotypes in oral rinses from HIV-positive and HIV-negative Jamaican patients.
    Rajendra Santosh AB; Christian NA; Jones T; Thoms-Rodriguez CA; Condappa A; Thompson T; Pinkney J; Barton EN; Lindo J
    J Investig Clin Dent; 2019 Feb; 10(1):e12365. PubMed ID: 30338674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence.
    Kreimer AR; Alberg AJ; Viscidi R; Gillison ML
    Sex Transm Dis; 2004 Apr; 31(4):247-56. PubMed ID: 15028941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of oral human papillomavirus infection among Indian HIV-positive men who have sex with men: a cross-sectional study.
    Hernandez AL; Karthik R; Sivasubramanian M; Raghavendran A; Lensing S; Lee JY; Abraham P; Mathai D; Palefsky JM
    BMC Infect Dis; 2021 Jul; 21(1):675. PubMed ID: 34247583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of and Risk Factors for Oral Human Papillomavirus Infection among HIV-Positive and HIV-Negative People Who Inject Drugs.
    Robbins HA; Fennell CE; Gillison M; Xiao W; Guo Y; Wentz A; Kirk GD; Mehta SH; D'Souza G
    PLoS One; 2015; 10(11):e0143698. PubMed ID: 26600158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women.
    Strickler HD; Palefsky JM; Shah KV; Anastos K; Klein RS; Minkoff H; Duerr A; Massad LS; Celentano DD; Hall C; Fazzari M; Cu-Uvin S; Bacon M; Schuman P; Levine AM; Durante AJ; Gange S; Melnick S; Burk RD
    J Natl Cancer Inst; 2003 Jul; 95(14):1062-71. PubMed ID: 12865452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral human papillomavirus infection in HIV-negative and HIV-infected MSM.
    Mooij SH; Boot HJ; Speksnijder AG; Stolte IG; Meijer CJ; Snijders PJ; Verhagen DW; King AJ; de Vries HJ; Quint WG; van der Sande MA; Schim van der Loeff MF
    AIDS; 2013 Aug; 27(13):2117-28. PubMed ID: 24384590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.